Original Research
Published on 11 May 2022
A Combination of Cytokine-Induced Killer Cells With PD-1 Blockade and ALK Inhibitor Showed Substantial Intrinsic Variability Across Non-Small Cell Lung Cancer Cell Lines
in Thoracic Oncology
![A Combination of Cytokine-Induced Killer Cells With PD-1 Blockade and ALK Inhibitor Showed Substantial Intrinsic Variability Across Non-Small Cell Lung Cancer Cell Lines](https://www.frontiersin.org/files/myhome article library/713476/713476_Thumb_400.jpg)
- 4,194 views
- 9 citations